Boc-His-NHNH2

Boc-His-NHNH2 is a Boc-protected histidine derivative bearing a hydrazide (-NHNH2) functionality at the C-terminus, providing a protected amino acid building block format for downstream coupling and functional transformation. The Boc group on the α-amino position supports controlled peptide/segment assembly under standard protected-amino-acid workflows, while the terminal hydrazide enables further derivatization to hydrazone-forming handles and related medicinal chemistry intermediates. This combination makes the reagent particularly useful for constructing histidine-containing fragments and for preparing C-terminally functionalized intermediates used in chemical biology and pharmaceutical intermediate development.

1. C-Terminal Hydrazide Intermediates

Boc-His-NHNH2 is used to prepare histidine-derived hydrazide intermediates for medicinal chemistry and synthetic chemistry programs that require a reactive -NHNH2 motif. Researchers commonly convert the hydrazide into hydrazone derivatives or other hydrazide-based functional scaffolds to support structure-activity relationship (SAR) studies, fragment elaboration, or late-stage functionalization strategies. The Boc protection helps maintain the histidine α-amino functionality during the early stages of synthesis, while the hydrazide group provides a distinct, orthogonal reactive site for subsequent derivatization.

2. Protected Histidine Segment Building Block

Boc-His-NHNH2 serves as a protected histidine building block for assembling histidine-containing peptide fragments and constrained synthetic segments where a C-terminal hydrazide is required as the endpoint functionality. Peptide synthesis and custom peptide manufacturing teams use this type of protected amino acid derivative when the target sequence or intermediate must terminate in a hydrazide rather than a free carboxylate or standard amide. The Boc group supports controlled coupling chemistry by keeping the α-amino functionality protected until the desired stage of fragment assembly, enabling reliable handling in multistep workflows and facilitating downstream conversion of the hydrazide-bearing terminus.

3. Chemical Biology Linker Development

Boc-His-NHNH2 is also employed in chemical biology workflows that require a histidine-based handle bearing a hydrazide functional group for conjugation or probe construction. In practice, researchers use the hydrazide functionality to introduce reactive sites that can be incorporated into labeled or affinity-tagged constructs, including systems where hydrazide chemistry is leveraged to generate specific coupling points after the core scaffold is assembled. The presence of the protected amino acid backbone helps maintain compatibility with protected-fragment synthesis strategies, allowing the hydrazide to be installed at a defined position for subsequent attachment to biomolecule-compatible partners.

4. Pharmaceutical Intermediate Synthesis

Boc-His-NHNH2 is used as a pharmaceutical intermediate building block for producing histidine-containing C-terminal hydrazide structures that feed into broader small-molecule synthesis routes. Process development and medicinal chemistry teams select this derivative when they need a stable, isolable protected amino acid intermediate that carries a terminal -NHNH2 functionality for downstream transformations into more advanced intermediates. The combination of Boc protection and hydrazide reactivity supports stepwise manufacturing logic, where the histidine fragment is introduced in a controlled protected form before the terminal hydrazide is converted into the next synthetic functionality required for target-directed synthesis.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists